STACEY LITZINGER: Open Payments
NPI 1003871245 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $51 |
| Lilly USA, LLC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Eisai Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: NUPLAZID, PONVORY, Leqembi, AMYVID, AUSTEDO XR, KEVEYIS, EMGALITY, VYEPTI.
Industry payments across PA — which companies pay providers there.
